Home › Nasopharyngeal Carcinoma › Illinois › Chicago
Nasopharyngeal Carcinoma clinical trials in Chicago, IL
3 studies for Nasopharyngeal Carcinoma are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
RecruitingPhase 2
- Northwestern University, Chicago
- University of Illinois, Chicago
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
RecruitingPhase 2
- Lurie Children's Hospital-Chicago, Chicago
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
- Northwestern University, Chicago
Nasopharyngeal Carcinoma trials in other cities
- Atlanta, GA6 studies
- Houston, TX3 studies
- Los Angeles, CA3 studies
- Pittsburgh, PA3 studies
- Richmond, VA3 studies
- Cincinnati, OH3 studies
- Milwaukee, WI3 studies
- Washington, DC3 studies
- Oklahoma City, OK3 studies
- Charlotte, NC3 studies
- San Francisco, CA3 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer59 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Lung Cancer41 studies
- Obesity41 studies
- Ovarian Cancer36 studies
- Colorectal Cancer34 studies
- Stroke34 studies
- Heart Failure31 studies
- Overweight29 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.